Stephen L. Hurst
Director, Definium Therapeutics.
Companies
- Definium TherapeuticsBoard member Jan 10, 2022 to Jan 10, 20221
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Definium Therapeutics DFTX1,722,778 shares2$59.1M at $34.31Jan 10, 2022
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARDefinium Therapeutics, Board member
- 2